2012
DOI: 10.1038/aps.2011.167
|View full text |Cite
|
Sign up to set email alerts
|

Association of ALOX15 gene polymorphisms with obesity-related phenotypes in Chinese nuclear families with male offspring

Abstract: Aim: Genetic variation in ALOX12, which encoded human 12-lipoxygenase, was found to be associated with fat mass in young Chinese men. The objective of this study was to investigate the relationship between single nucleotide polymorphisms (SNPs) and haplotypes in the ALOX15 gene and obesity-related phenotypes in Chinese nuclear families with male offspring. Methods: We recruited 1,296 subjects from 427 nuclear families with male offspring and genotyped five SNPs (rs9894225, rs748694, rs2619112, rs2619118, and r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 46 publications
(52 reference statements)
0
2
0
Order By: Relevance
“…Epidemiological studies have reported associations, albeit inconsistent, between genetic variation in both the ALOX12 and ALOX15 genes and bone properties [15--20], and with body Page 4 of 20 composition and fat mass [21,22]. Strengthening their putative role as candidate genes for osteoporosis, ALOX12/15 metabolites can act as ligands for peroxisome proliferator--activated receptor gamma (PPARγ) [23].…”
Section: Introductionmentioning
confidence: 99%
“…Epidemiological studies have reported associations, albeit inconsistent, between genetic variation in both the ALOX12 and ALOX15 genes and bone properties [15--20], and with body Page 4 of 20 composition and fat mass [21,22]. Strengthening their putative role as candidate genes for osteoporosis, ALOX12/15 metabolites can act as ligands for peroxisome proliferator--activated receptor gamma (PPARγ) [23].…”
Section: Introductionmentioning
confidence: 99%
“…Each enrolled subject was asked to answer questions concerning their demographic characteristics, lifestyle, dietary habits, and tobacco/alcohol use. The study participant exclusion criteria were as follows: (1) significant health problems due to cerebral vascular disease; (2) diabetes; (3) chronic kidney, liver, or lung disease; (4) alcoholism; (5) pharmacologic doses of corticosteroids for >3 months; (6) anticonvulsant therapy for >6 months; (7) evidence of other hereditary or metabolic bone diseases; (8) rheumatoid arthritis or a collagen disease; (9) major gastrointestinal disease within the last year; (10) any major endocrinopathy that would affect bone mass such as hyperthyroidism, hypogonadism, or hypercortisolism; (11) any neurological or musculoskeletal condition that might cause secondary low bone mass (16,(24)(25)(26)(27)(28)(29)(30).…”
Section: Subjectsmentioning
confidence: 99%